We are live on ! Find out more
GTC

Ghost Tree Capital Portfolio holdings

AUM $331M
1-Year Est. Return 70.11%
This Fund
S&P 500
This Quarter Est. Return
+24.07%
1 Year Est. Return
+70.11%
3 Year Est. Return
+265.05%
5 Year Est. Return
+3,034.98%
10 Year Est. Return
+22,104.75%
AUM
$163M
AUM Growth
–
Cap. Flow
+$196M
Cap. Flow %
120.52%
Top 10 Hldgs %
40.87%
Holding
62
New
62
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$9.4M
2
BMY icon
Bristol-Myers Squibb
BMY
+$5.09M
3
BIIB icon
Biogen
BIIB
+$4.14M
4
SPNC
Spectranetics Corp
SPNC
+$3.75M
5
ARAY icon
Accuray
ARAY
+$3.49M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 50.1%
2 Technology 0.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SGNT
26
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
$2.54M 1.56%
+100,000
New +$2.26M
GNMK
27
DELISTED
GenMark Diagnostics, Inc
GNMK
$2.52M 1.55%
+190,000
New +$2.31M
BRKR icon
28
Bruker
BRKR
$9.02B
$2.27M 1.4%
+115,000
New +$2.26M
HOLX
29
CALL
DELISTED
Hologic
HOLX
$2.23M 1.38%
+100,000
New +$2.2M
SGMO
30
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$2.08M 1.28%
+150,000
New +$1.73M
AUXL
31
CALL
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
$2.07M 1.28%
+100,000
New +$1.89M
LCI
32
DELISTED
Lannett Company, Inc.
LCI
$1.99M 1.22%
+15,000
New +$1.59M
TRNX
33
DELISTED
TORNIER N V SHARES (NLD)
TRNX
$1.88M 1.16%
+100,000
New +$1.89M
VOLC
34
DELISTED
VOLCANO CORPORATION COM STK
VOLC
$1.86M 1.14%
+85,000
New +$1.88M
CLVS
35
DELISTED
Clovis Oncology, Inc.
CLVS
$1.81M 1.11%
+30,000
New +$1.63M
CELG
36
DELISTED
Celgene Corp
CELG
$1.69M 1.04%
+20,000
New +$1.58M
TEAR
37
DELISTED
TearLab Corporation
TEAR
$1.64M 1.01%
+17,500
New +$1.74M
UNIS
38
DELISTED
Unilife Corporation
UNIS
$1.54M 0.95%
+35,000
New +$1.28M
HOLX
39
DELISTED
Hologic
HOLX
$1.45M 0.89%
+65,000
New +$1.43M
BMRN icon
40
BioMarin Pharmaceuticals
BMRN
$11.6B
$1.41M 0.87%
+20,000
New +$1.36M
JAZZ icon
41
Jazz Pharmaceuticals
JAZZ
$15.2B
$1.27M 0.78%
+10,000
New +$1.03M
OSUR icon
42
OraSure Technologies
OSUR
$273M
$1.26M 0.77%
+200,000
New +$1.26M
NXTM
43
DELISTED
NxStage Medical Inc.
NXTM
$1.25M 0.77%
+125,000
New +$1.42M
AIRM
44
DELISTED
Air Methods Corp
AIRM
$1.17M 0.72%
+20,000
New +$997K
TNDM icon
45
Tandem Diabetes Care
TNDM
$1.12B
$1.16M 0.71%
+4,500
New +$1.03M
GERN icon
46
Geron
GERN
$911M
$1.11M 0.69%
+248,630
New +$1.07M
MASI
47
DELISTED
Masimo
MASI
$1.02M 0.63%
+35,000
New +$980K
BEAT
48
DELISTED
BioTelemetry, Inc.
BEAT
$993K 0.61%
+125,000
New +$1.17M
OCRX
49
DELISTED
Ocera Therapeutics, Inc.
OCRX
$974K 0.6%
+75,000
New +$701K
AVDL
50
DELISTED
Avadel Pharmaceuticals
AVDL
$966K 0.59%
+120,000
New +$847K
1
2
3

Similar funds

SF
Susquehanna Foundation Bala Cynwyd, Pennsylvania $333M AUM 35.73% 1-Year Est. Return
AFS
Annapolis Financial Services Annapolis, Maryland $338M AUM 23.49% 1-Year Est. Return
SFA
Source Financial Advisors New York $338M AUM 33.62% 1-Year Est. Return
E
ETFidea Syracuse, New York $316M AUM 29.57% 1-Year Est. Return
OHCM
Oak Hill Capital Management New York $310M AUM 17.23% 1-Year Est. Return
MC
Minot Capital Broomfield, Colorado $353M AUM 25.25% 1-Year Est. Return
BRA
Biechele Royce Advisors Fishers, Indiana $303M AUM 20.64% 1-Year Est. Return
S
Syntrinsic Denver, Colorado $301M AUM 27.27% 1-Year Est. Return

Ghost Tree Capital's Q4 2013 Portfolio in Review

Q4 2013 is the first quarter with a 13F filing on record for Ghost Tree Capital, which disclosed 62 positions worth $163M. Its ten largest holdings account for 41% of the portfolio.

Its largest position is Gilead Sciences: 135,000 shares worth $10.1M.

By sector, the portfolio is most concentrated in Healthcare at 50% of assets, followed by Technology.

  • Ghost Tree Capital's largest Q4 2013 buy was Gilead Sciences: 135,000 shares worth $10.1M.
  • Ghost Tree Capital's ten largest holdings make up 41% of its $163M portfolio in Q4 2013.
  • Ghost Tree Capital disclosed 62 positions in Q4 2013, its first 13F filing on record.

Based on Ghost Tree Capital's 13F filing for Q4 2013, filed 14 Feb 2014.